S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

RATIONALE: Serotonin (5-HT)(2C) receptors are implicated in the control of mood, and their blockade is of potential interest for the management of anxiodepressive states. OBJECTIVES: Herein, we characterized the in vitro and in vivo pharmacological profile of the novel benzourea derivative, S32006....

Descrizione completa

Dettagli Bibliografici
Autori principali:	Dekeyne, A, Mannoury la Cour, C, Gobert, A, Brocco, M, Lejeune, F, Serres, F, Sharp, T, Daszuta, A, Soumier, A, Papp, M, Rivet, J, Flik, G, Cremers, T, Muller, O, Lavielle, G, Millan, M
Natura:	Journal article
Lingua:	English
Pubblicazione:	2008

Documenti analoghi

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.
di: Millan, M, et al.
Pubblicazione: (2004)

S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
di: Dekeyne, A, et al.
Pubblicazione: (2012)

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.
di: Karolina Pytka, et al.
Pubblicazione: (2015-01-01)

Brain Targeting of Antidepressant and Anxiolytic Drugs
di: Jéssica Antunes, et al.
Pubblicazione: (2022-12-01)

Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats
di: Wesołowska A, et al.
Pubblicazione: (2021-06-01)

5‐HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
di: Julie Meffre, et al.
Pubblicazione: (2012-10-01)

Self-medication with anxiolytics and antidepressants: main risk factors and repercussions
di: Francisco A. Mateos-Mauricio
Pubblicazione: (2024-01-01)

Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
di: Serres, F, et al.
Pubblicazione: (2012)

Antidepressant and Anxiolytic Potentials of the Chewing Stick, Salvadora persica
di: Rajalakshimi Vasudevan, et al.
Pubblicazione: (2023-01-01)

Evaluation of antidepressant and anxiolytic activity of phosphodiesterase 3 inhibitor - Cilostazol
di: Dipesh S Patel, et al.
Pubblicazione: (2012-01-01)

S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms
di: Indira Mendez-David, et al.
Pubblicazione: (2017-07-01)

Antidepressant, Anxiolytic and Antinociceptive Activities of Constituents from Rosmarinus Officinalis
di: Abeer Abdelhalim, et al.
Pubblicazione: (2015-09-01)

Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose
di: Vestergaard, P, et al.
Pubblicazione: (2013)

Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
di: Vestergaard, P, et al.
Pubblicazione: (2013)

Fractures in users of antidepressants and anxiolytics and sedatives effects of age and dose
di: Vestergaard, P, et al.
Pubblicazione: (2012)

Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
di: Charles F. Zorumski, et al.
Pubblicazione: (2019-11-01)

Anxiolytic and Antidepressant Effect of Phaseolus vulgaris on Animal Models
di: Rabia Munawwar, et al.
Pubblicazione: (2024-01-01)

Anxiolytic and Antidepressant Potential of Methanolic Extract of Linn. in Mice
di: Ahmed Awais Khalid, et al.
Pubblicazione: (2023-04-01)

Antidepressant and Anxiolytic Effects of Cod Liver Oil in Rats
di: Tahira Perveen*, Faiza Razi, Saida Haider, Hina Qayyum and Darakhshaan J. Haleem
Pubblicazione: (2013-01-01)

Anxiolytic, antidepressant and antioxidant activity of the methanol extract of Canarium resiniferum leaves
di: Md Shahin Shah, et al.
Pubblicazione: (2022-11-01)

Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic
di: Mikael Tiger, et al.
Pubblicazione: (2024-04-01)

A Molecular Docking Study on Natural Compounds as Anxiolytics and Antidepressants
di: Maria Mernea, et al.
Pubblicazione: (2022-11-01)

The Anxiolytic and Antidepressant Effect of Tanacetum polycephalum in the Pentylenetetrazole Kindled Rats
di: Vahid Azizi, et al.
Pubblicazione: (2020-04-01)

Examining the short-term anxiolytic and antidepressant effect of Floatation-REST.
di: Justin S Feinstein, et al.
Pubblicazione: (2018-01-01)

Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
di: Erin L. Martin, et al.
Pubblicazione: (2021-09-01)

Comparative Evaluation of Antidepressant and Anxiolytic Effects of Escitalopram, Crocin, and their Combination in Rats
di: Mehran Joodaki, et al.
Pubblicazione: (2024-10-01)

Antidepressant and Anxiolytic Effects of Fermented Huauzontle, a Prehispanic Mexican Pseudocereal
di: Lourdes Santiago-López, et al.
Pubblicazione: (2022-12-01)

Antidepressant, Anxiolytic and Neuroprotective Activities of Two Zinc Compounds in Diabetic Rats
di: Christiane Leite Cavalcanti, et al.
Pubblicazione: (2020-01-01)

Anxiolytic and antidepressants’ effect of Crataegus pinnatifida (Shan Zha): biochemical mechanisms
di: Keren Nitzan, et al.
Pubblicazione: (2022-05-01)

Exogenous Carbon Monoxide Produces Rapid Antidepressant- and Anxiolytic-Like Effects
di: Yixiao Luo, et al.
Pubblicazione: (2021-11-01)

Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
di: Lewis, G, et al.
Pubblicazione: (2011)

Anxiolytic and antidepressant effects of cinnamon (Cinnamomum verum) extract in rats receiving lead acetate
di: Fadaei S, et al.
Pubblicazione: (2018-02-01)

Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments.
di: Gartside, SE, et al.
Pubblicazione: (1992)

Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments.
di: Guilloux, J, et al.
Pubblicazione: (2011)

The antidepressant and anxiolytic effects of cannabinoids in chronic unpredictable stress: a preclinical systematic review and meta-analysis
di: Noa Reuveni, et al.
Pubblicazione: (2022-05-01)

Antidepressant‐ and Anxiolytic‐Like Effect of the Froriepia subpinnata Extract in the Rat: Neurochemical Correlates
di: Mohammad R. Samandari‐Bahraseman, et al.
Pubblicazione: (2024-11-01)

Food-derived protein hydrolysates and peptides: anxiolytic and antidepressant activities, characteristics, and mechanisms
di: Wenhui Li, et al.
Pubblicazione: (2024-05-01)

Methylone, a rapid acting entactogen with robust anxiolytic and antidepressant-like activity
di: Jennifer Warner-Schmidt, et al.
Pubblicazione: (2023-01-01)

CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication
di: Kaerlev Linda, et al.
Pubblicazione: (2012-05-01)

Higher prescription of antidepressants and/or anxiolytics among chronic obstructive pulmonary disease patients
di: Charlotte E. Pelgrim, et al.
Pubblicazione: (2021-03-01)